{"date":"2026-01-02","count":8,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7773-2026-01-02-2041-6q9z82","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-02","time":"20:41:20","subject":"本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與醫療財團法人徐元智先生醫藥基金會亞東紀念醫院申請之細胞製備場所認可增列施行機構，獲衛福部認可","clause":"第44款","fact_date":"2026-01-02","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-01-02 20:41，「本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與醫療財團法人徐元智先生醫藥基金會亞東紀念醫院申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-01-02-2038-zw0h3g","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-02","time":"20:38:16","subject":"本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與臺北醫學大學附設醫院申請之細胞製備場所認可增列施行機構，獲衛福部認可","clause":"第44款","fact_date":"2026-01-02","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-01-02 20:38，「本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與臺北醫學大學附設醫院申請之細胞製備場所認可增列施」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-01-02-1831-17rf92l","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-01-02","time":"18:31:28","subject":"代重要子公司富康活力醫藥(股)公司公告處分(轉租)使用權資產予關係人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-01-02 18:31，「代重要子公司富康活力醫藥(股)公司公告處分(轉租)使用權資產予關係人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-01-02-1831-mn8o6r","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-01-02","time":"18:31:04","subject":"代重要子公司富康活力醫藥(股)公司公告向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-01-02 18:31，「代重要子公司富康活力醫藥(股)公司公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-01-02-1538-ixagl9","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-01-02","time":"15:38:55","subject":"公告本公司賓達妥注射劑(BendaReady Injection)已獲衛生福利部核准，取得首支Bendamustine新劑型新藥之藥品許可證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-01-02 15:38，「公告本公司賓達妥注射劑(BendaReady Injection)已獲衛生福利部核准，取得首支Bendamustine新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-01-02-1526-p67uuk","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-01-02","time":"15:26:28","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-01-02 15:26，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-01-02-1503-8jxpj","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-01-02","time":"15:03:49","subject":"公告本公司與聖展生技股份有限公司股份轉換之股份轉換基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-01-02 15:03，「公告本公司與聖展生技股份有限公司股份轉換之股份轉換基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-01-02-1430-m5fqme","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-01-02","time":"14:30:40","subject":"公告本公司辦理114年第1次現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-01-02 14:30，「公告本公司辦理114年第1次現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}